{"id":365093,"date":"2019-05-08T10:35:01","date_gmt":"2019-05-08T10:35:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=365093"},"modified":"2019-05-08T10:35:01","modified_gmt":"2019-05-08T10:35:01","slug":"increasing-prevalence-of-diabetes-is-boosting-the-global-diabetes-drugs-market-by-650-cagr-through-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/increasing-prevalence-of-diabetes-is-boosting-the-global-diabetes-drugs-market-by-650-cagr-through-2027_365093.html","title":{"rendered":"Increasing Prevalence of Diabetes Is Boosting the Global Diabetes Drugs Market by 6.50% CAGR Through 2027"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/05\/1557292167.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/05\/1557292167.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Global Diabetes Drugs market was valued around $34,296 million in 2018 and is anticipated to hit nearly $60,435 million by 2027, at an estimated CAGR of 6.50%, during the forecast period 2019-2027.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">According to the new market research report launched by Inkwood Research, The Global Diabetes Drugs market was valued around $34,296 million in 2018 and is anticipated to hit nearly $60,435 million by 2027, at an estimated CAGR of 6.50%, during the forecast period 2019-2027.<\/div>\n<p style=\"text-align: justify;\">Browse 22 market data Tables and 33 Figures spread through 172 Pages and in-depth analysis on <a href=\"https:\/\/www.inkwoodresearch.com\/reports\/diabetes-drugs-market\/\">Global Diabetes Drugs&nbsp;market<\/a> by Diabetes Type( Type 1, Type 2) by Product Class( Insulin (Fast Acting Insulin, Intermediate Acting Insulin, Long-acting Insulin) Non-Insulin (DPP-4 Inhibitor, GLP-1 Receptors Agonists, SGLT-2 Inhibitors)) &amp; by Geography.<\/p>\n<p style=\"text-align: justify;\">This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World, the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.<\/p>\n<p style=\"text-align: justify;\"><strong>Diabetes Drugs market scenario<\/strong><\/p>\n<p style=\"text-align: justify;\">The increase in the prevalence of diabetes advances in insulin delivery technology and the growing elderly population can be credited for the significant expansion of the global diabetes drugs&nbsp;market.<\/p>\n<p style=\"text-align: justify;\">The Diabetes Drugs market report provides data tables, includes charts and graphs for visual analysis.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Free Sample Report for Global Diabetes Drugs Market by Product Class, Diabetes Type &amp; Geography.<\/strong> <a href=\"https:\/\/www.inkwoodresearch.com\/reports\/diabetes-drugs-market\/#request-free-sample\">https:\/\/www.inkwoodresearch.com\/reports\/diabetes-drugs-market\/#request-free-sample<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Market Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">On the basis of Product Class, the Global Diabetes Drugs market is segmented as follows<\/p>\n<ul style=\"text-align: justify;\">\n<li>Insulin<\/li>\n<ul>\n<li>Fast acting insulin<\/li>\n<li>Intermediate-acting insulin<\/li>\n<li>Long-acting insulin<\/li>\n<\/ul>\n<li>Non-insulin<\/li>\n<ul>\n<li>DPP-4 inhibitor<\/li>\n<li>GLP-1 receptors agonists<\/li>\n<li>SGLT-2 inhibitors<\/li>\n<li>Other non-insulin drugs<\/li>\n<\/ul>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;On the basis of Diabetes Type, the Global Diabetes Drugs market is segmented as follows:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Type 1<\/li>\n<li>Type 2<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Report Highlights<\/strong><br \/> &#8211; The report provides a detailed analysis of current and future market trends to identify the investment opportunities<br \/> &#8211; Market forecasts till 2027, using estimated market values as the base numbers<br \/> &#8211; Key market trends across the business segments, regions and countries<br \/> &#8211; Key developments and strategies observed in the market<br \/> &#8211; Market dynamics such as drivers, restraints, opportunities and other trends<br \/> &#8211; In-depth company profiles of key players and upcoming prominent players<br \/> &#8211; Growth prospects among the emerging nations through 2027<\/p>\n<p style=\"text-align: justify;\"> <strong>Companies Profiled<\/strong><\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ELI LILLY AND COMPANY<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ASTELLAS PHARMA<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; B.BRAUN MELSUNGEN AG<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NOVO NORDISK A\/S<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DIAVACS INC.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SANOFI<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ASTRAZENECA PLC<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALBIREO PHARMA INC.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MACROGENICS, INC.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XOMA CORP.<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GLAXOSMITHKLINE<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XERIS PHARMACEUTICALS<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MERCK<\/p>\n<p style=\"text-align: justify;\">&#8211;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PFIZER<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/global-pain-management-drugs-market-forecast-2019-2027\/\">Pain Management Drugs market<\/a>&#8211; Global pain management drugs market is estimated to grow with approx. 3.88% CAGR during the year 2019-2027.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/reports\/global-hyperphosphatemia-drug-market\/\">Hyperphosphatemia drug market<\/a> &#8211; Global automotive paints &amp; coatings market is expected to grow at a 16.13% CAGR during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.inkwoodresearch.com\/global-atopic-dermatitis-drugs-market-at-4-77-cagr-by-2027-3\/\">Global Atopic Dermatitis Drugs Market<\/a> &#8211; Global Atopic Dermatitis Drugs market is estimated to grow with approx. 4.77% CAGR during the year 2019-2027.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/inkwoodresearch.com_26191.html\" rel=\"nofollow\">Inkwood Research<\/a><br \/><strong>Contact Person:<\/strong> Clive Cooper<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=increasing-prevalence-of-diabetes-is-boosting-the-global-diabetes-drugs-market-by-650-cagr-through-2027\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 857-302-4704<br \/><strong>City:<\/strong> Boston<br \/><strong>State:<\/strong> MA<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.inkwoodresearch.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.inkwoodresearch.com\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=increasing-prevalence-of-diabetes-is-boosting-the-global-diabetes-drugs-market-by-650-cagr-through-2027\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Global Diabetes Drugs market was valued around $34,296 million in 2018 and is anticipated to hit nearly $60,435 million by 2027, at an estimated CAGR of 6.50%, during the forecast period 2019-2027.&#8221; According to the new market research report launched &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/increasing-prevalence-of-diabetes-is-boosting-the-global-diabetes-drugs-market-by-650-cagr-through-2027_365093.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-365093","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/365093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=365093"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/365093\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=365093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=365093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=365093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}